Ledger.Open graph →
SEC Form D · filed July 16, 2018

Atea Pharmaceuticals, Inc

Offering
$27.6M
Sold
$27.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Simon R. Yeh · San Francisco, CADirectorSean M. Mcavoy · Burlingame, CADirectorPaul M. Galvin · Brooklyn, NYDirectorMahesh S. Shetty · Brooklyn, NYDirectorSonia K. Lutchmiah · Moka, O4DirectorSimon R. Goldman · San Francisco, CAExecBalan R. Ayyar · Brooklyn, NYDirectorLucien A. Alziari · Newark, NJDirectorZiad Khoury · Winter Park, FLDirectorJason Rottenberg · Winter Park, FLDirectorEvgeny Zaytsev · San Francisco, CAExecPhilip Sawyer · San Francisco, CADirectorJean-Pierre Sommadossi · Framingham, MAExec · DirectorFan Yu · Irvine, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗